International scientific society · Founded 2026
About the Society ASTRO 2023 IJRM-SSS — The Orange Journal
SIRiiM International Society for Radiation Medicine, Immunity and Immunomodulation

Home / Education / Arthritis

Indication

Arthritis and low-dose radiation

Osteoarthritis and related enthesopathies are the most mature benign indication for low-dose radiation in routine European practice. SIRiiM teaches that as immunomodulation — not as a treatment advertisement.

Why this indication is on the Society syllabus

At low doses, radiation has a documented anti-inflammatory effect. For osteoarthritis of the hands, knees, shoulders and other joints, a short course of targeted low-dose radiation is used in parts of Europe when injections, physical therapy or medications have not given lasting relief. Sessions are brief. Doses are low. Relief, when it comes, is usually gradual rather than immediate.

The DEGRO practical guidelines on radiotherapy of non-malignant disorders treat this family of indications as having an experimental basis in leukocyte, endothelial and macrophage biology — and they are explicit that radiogenic risk must still be weighed whenever radiation is used for a benign condition.1

Joints and related conditions in the teaching set

  • Osteoarthritis of the hands, fingers and thumb
  • Knee, shoulder, hip and elbow arthritis
  • Heel pain and plantar fasciitis
  • Related degenerative and enthesopathic pain

Adjacent inflammatory and fibrotic conditions that appear on radiation-rheumatology lists — Dupuytren contracture, Ledderhose, keloids, hidradenitis, heterotopic ossification — are related teaching problems. They are not automatically Society endorsements, and several remain case-series evidence only.

What a PCP should take from this

LDRT for osteoarthritis is not “radiation for cancer, turned down.” It is an immunological intervention in a non-malignant disease, with a decades-long tail of radiogenic risk that younger patients carry more of. The comparator is best available care — not nothing. See the PCP LDRT tutorial.

Under-used is not the same as proven for everyone. The Society’s position is that this is the most mature benign indication on the list, and still under-used in US practice relative to the European guideline literature. That is a practice-pattern statement, not a prescription.

Where this sits on the research agenda

SIRiiM’s broader candidate list — refractory plaque psoriasis, hidradenitis, pancreatitis, infectious pneumonia — is a research agenda, not a menu. COVID-19 pneumonia has randomised evidence that is negative in ventilated patients. Furuncles have historical interest and a modern standard of care that does not need a beam. Arthritis is taught separately because its evidence state is different. Read immunity before treating any of those sentences as interchangeable.

Informational Society education, not medical advice. Nothing on this page is an offer of treatment. Patients should confirm any option with their own care team.

References

  1. Reichl B, Block A, Schäfer U, et al. DEGRO practical guidelines for radiotherapy of non-malignant disorders: part I. Strahlenther Onkol. 2015;191(9):701–709. doi:10.1007/s00066-015-0865-8
  2. Rödel F, Frey B, Manda K, et al. Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation. Front Oncol. 2012;2:120. doi:10.3389/fonc.2012.00120